About Bihans Pharmaceuticals Private Limited
Data last updated:
Bihans Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24304MH2017PTC289916. Its GSTIN is 27AAHCB0905H1ZY (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vipul Harikishan Sobti and Ankit Harikishan Sobti.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 616 Hans Sadan Indora Chowk Kamptee Road, Nagpur, Maharashtra, India – 440017.
As per the financials filed for FY 2025, the company reported a revenue of ₹63.01 Lakh, a growth of 58% compared to the previous year. For the same year it recorded a net profit of ₹59,773 (net margin 0.9%) and EBITDA of ₹3.66 Lakh (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 9% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bihanspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No 616 Hans Sadan Indora Chowk Kamptee Road, Nagpur, Maharashtra, India – 440017
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bihans Pharmaceuticals Private Limited
The main business activity of Bihans Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bihans Pharmaceuticals Private Limited FY 2025 filings available
Bihans Pharmaceuticals Private Limited reported revenue of ₹63.01 Lakh (up 58% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Bihans Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 58% growth in the latest year. EBITDA rose 122% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Bihans Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.66 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹59,773 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Bihans Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bihans Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Bihans Pharmaceuticals Private Limited
Bihans Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sarvam Jothy Pharmaceuticals Private Limited | ₹63.26 Lakh (FY 2024) | •••• | •••• | 968.0% | •••• | Chennai, Tamil Nadu, India |
| Tanik Pharmaceuticals Private Limited | ₹63.19 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Chennai, Tamil Nadu, India |
| Genderma Pharmaceuticals Private Limited | ₹63.13 Lakh (FY 2025) | •••• | •••• | -26.0% | •••• | Uttar Pradesh, India |
| Susruta Pharmaceuticals Private Limited | ₹63.09 Lakh (FY 2022) | •••• | •••• | -26.0% | •••• | Kolkata, West Bengal, India |
| Nicd Pharmaceuticals Private Limited | ₹63.03 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Tenali, Andhra Pradesh, India |
| Bihans Pharmaceuticals Private Limited this company | ₹63.01 Lakh (FY 2025) | •••• | •••• | 58.0% | •••• | Nagpur, Maharashtra, India |
| Acer Pharmaceuticals Private Limited | ₹62.91 Lakh (FY 2025) | •••• | •••• | 32.0% | •••• | Chennai, Tamil Nadu, India |
| Jysrox Pharmaceuticals Private Limited | ₹62.91 Lakh (FY 2024) | •••• | •••• | 1.0% | •••• | Hyderabad, Telangana, India |
| Innings Pharmaceuticals Private Limited | ₹62.87 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | Delhi, India |
| Wellshark Pharmaceuticals Private Limited | ₹62.83 Lakh (FY 2024) | •••• | •••• | -27.0% | •••• | Hyderabad, Telangana, India |
| Organcare Pharmaceuticals Private Limited | ₹62.81 Lakh (FY 2025) | •••• | •••• | 28.0% | •••• | Indore, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Bihans Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Bihans Pharmaceuticals Private Limited
Bihans Pharmaceuticals Private Limited is audited by J S UBEROI & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| J S UBEROI & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Bihans Pharmaceuticals Private Limited
Bihans Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vipul Harikishan Sobti | Director | 14 Jun 2021 | 5 Years 3 Months | Current |
| Ankit Harikishan Sobti | Director | 25 Jan 2017 | 9 Years 8 Months | Current |
| Harikishan Harbans Singh Sobti | Director | 25 Jan 2017 | 9 Years 8 Months | Current |
Ownership and Shareholding of Bihans Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Bihans Pharmaceuticals Private Limited
Bihans Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bihans Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Bihans Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bihans Pharmaceuticals Private Limited
Bihans Pharmaceuticals Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Vipul Harikishan Sobti was appointed as Director on 14 Jun 2021.
Credit Ratings, Litigation & Regulatory Alerts for Bihans Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bihans Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bihans Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bihans Pharmaceuticals Private Limited
Bihans Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCB0905H1ZY | Maharashtra | Active | 27 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bihans Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bihans Pharmaceuticals Private Limited
Bihans Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 January 2017 (9+ years old) and is registered under CIN U24304MH2017PTC289916.
Bihans Pharmaceuticals reported revenue of ₹63.01 Lakh for FY 2025 (up 58% YoY).
Bihans Pharmaceuticals has 3 current directors:
- Vipul Harikishan Sobti - Director
- Ankit Harikishan Sobti - Director
- Harikishan Harbans Singh Sobti - Director
Bihans Pharmaceuticals reported a net profit of ₹59,773 (net margin 0.9%) and EBITDA of ₹3.66 Lakh (EBITDA margin 5.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Bihans Pharmaceuticals is 16% over three years and 9% over five years. In the latest year (FY 2025) revenue rose 58%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Bihans Pharmaceuticals is 27AAHCB0905H1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Bihans Pharmaceuticals is U24304MH2017PTC289916. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bihans Pharmaceuticals was incorporated on 25 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Bihans Pharmaceuticals by revenue are Sarvam Jothy Pharmaceuticals Private Limited, Tanik Pharmaceuticals Private Limited, Genderma Pharmaceuticals Private Limited, Susruta Pharmaceuticals Private Limited, Nicd Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Vipul Harikishan Sobti was appointed as Director on 14 Jun 2021. Prashant Prakash Rangari ceased to be Director on 15 May 2019. Ankit Harikishan Sobti was appointed as Director on 25 Jan 2017. Bihans Pharmaceuticals has 4 board changes on record in total.
Bihans Pharmaceuticals can be reached through the website bihanspharma.com. Its registered office is in Nagpur, Maharashtra, India.